Health News Archive - September 03, 2009
Retail medical clinics in pharmacies and stores can provide routine care at lower cost than other facilities and offer similar quality, U.S. researchers said. The Rand Corp.
North American blueberry juice, biotransformed with bacteria from the fruit's skin, may be an anti-obesity and anti-diabetic agent, Canadian researchers say. Researchers at the Universite de Montreal, the Institut Armand-Frappier and the Universite de Moncton tested the effects of biotransformed juices compared to regular blueberry drinks on mice. Senior author Pierre S.
Exercise lowered breast cancer risk 52 percent of women entering or past menopause, Canadian researchers said. The study, published in the Journal of Cancer Epidemiology, reinforced the correlation between breast cancer and being overweight or a smoker. The study looked at 280 women with breast cancer and 280 women without cancer.
Current or past exposure to bullying in the workplace is associated with increased sleep disturbances, a researcher in Ireland said. Isabelle Niedhammer of the University College Dublin found 11 percent of women and 9 percent of men experienced hostile behavior in the work environment at least weekly and for at least six months during the previous 12 months.
Timing of prolonged orthopedic surgery may be key in treating trauma patients, German researchers suggest. In an article published in the Journal of the American Academy of Orthopaedic Surgeons, researchers suggests trauma patients who have several orthopedic injuries and are considered to be in unstable condition should only have a few hours of surgery when first arriving at a hospital. If you limit the amount of time in the operating room to less than three hours, patients appear to do better, study lead author Dr.
OSLO, September 3 /PRNewswire-FirstCall/ -- - Algeta Retains Option for Co-promotion and Profit Sharing in USA - Potential deal value of $800 million (EUR560m*) plus tiered double digit royalties - Algeta to receive $61 million (EUR42.5m) cash upfront, followed by development and sales milestones - Algeta retains option for co-promotion and profit-sharing in USA - Algeta and Bayer will jointly develop Alpharadin, with Bayer contributing a substantial majority of the costs of future development Algeta ASA (OSE:ALGETA), the cancer therapeutics company, announces today that it has entered into a global agreement with Bayer for the development and commercialization of Algeta's first-in-class alpha-pharmaceutical, Alpharadin.
VEENENDAAL, the Netherlands, September 3 /PRNewswire/ -- - Despite Challenging Global Economic Conditions, Nucletron Surpassed Projections for the First Half Year Nucletron, a global leader in radiation oncology, today announced strong financial results over the first half year of 2009.
FLANDREAU, S.D., Sept.
INDIANAPOLIS, Sept. 3 /PRNewswire/ -- Firefighter Joe Frolick, Wayne Township Fire Department, will attempt to set the Ohio state record for the most consecutive skydives at the Start Skydiving drop zone in Lebanon, Ohio on September 4, 2009.
BOTHELL, WA and VANCOUVER, Sept. 3 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc.
- Emitting flashes of light; glittering.